Mural Oncology Plc Stock Analysis

Mural Stock Analysis Notes

About 69.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Mural Oncology plc recorded a loss per share of 9.03. The entity had not issued any dividends in recent years. To find out more about Mural Oncology plc contact Caroline Loew at 353 1 905 8020 or learn more at https://www.muraloncology.com.

Mural Oncology plc Investment Alerts

Mural Oncology plc Upcoming and Recent Events

Mural Largest EPS Surprises

View All Earnings Estimates

Mural Oncology Environmental, Social, and Governance (ESG) Scores

Mural Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 63.98 M.

Mural Profitablity

Management Efficiency

Mural Oncology plc has return on total asset (ROA) of (0.8105) % which means that it has lost $0.8105 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7834) %, meaning that it created substantial loss on money invested by shareholders. Mural Oncology's management efficiency ratios could be used to measure how well Mural Oncology manages its routine affairs as well as how well it operates its assets and liabilities. As of February 2, 2025, Return On Tangible Assets is expected to decline to -0.65. In addition to that, Return On Capital Employed is expected to decline to -0.67. At present, Mural Oncology's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 22.5 M, whereas Other Current Assets are forecasted to decline to about 801.1 K.

Technical Drivers

As of the 2nd of February, Mural Oncology secures the Risk Adjusted Performance of 0.0499, mean deviation of 2.4, and Downside Deviation of 2.53. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mural Oncology plc, as well as the relationship between them.

Mural Oncology plc Price Movement Analysis

Mural Oncology plc Insider Trading Activities

Mural Oncology Outstanding Bonds

Mural Oncology Predictive Daily Indicators

Mural Oncology Corporate Filings

Mural Oncology Forecast Models

Mural Oncology's time-series forecasting models are one of many Mural Oncology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mural Oncology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mural Oncology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mural shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mural Oncology. By using and applying Mural Stock analysis, traders can create a robust methodology for identifying Mural entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mural analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mural analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Mural Oncology plc stock analysis indicators help investors evaluate how Mural Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mural Oncology shares will generate the highest return on investment. By understating and applying Mural Oncology stock analysis, traders can identify Mural Oncology position entry and exit signals to maximize returns.

When running Mural Oncology's price analysis, check to measure Mural Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mural Oncology is operating at the current time. Most of Mural Oncology's value examination focuses on studying past and present price action to predict the probability of Mural Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mural Oncology's price. Additionally, you may evaluate how the addition of Mural Oncology to your portfolios can decrease your overall portfolio volatility.